Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79468 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Nisoldipine Related Compound G (Diisobutyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C23H30N2O6Color and Shape:Yellow PowderMolecular weight:430.21039Ethylhexyl Triazone Related Compound B (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C40H50N6O6Color and Shape:PowderMolecular weight:710.86Calcitonin Salmon Related Compound B (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C147H242N44O50S2Color and Shape:Colorless LiquidMolecular weight:3487.71879Ioversol Related Compound A (5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) (DISCONTINUED)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C14H18I3N3O6Color and Shape:Off-White Tan Crystalline PowderMolecular weight:704.83298Amitraz Related Compound C (N,N'-Bis(2,4-dimethylphenyl)formimidamide) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:Aromatic imines and their derivatives, salts thereofFormula:C17H20N2Color and Shape:PowderMolecular weight:252.16265Rivaroxaban Open Ring ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H20ClN3O4SColor and Shape:Off-White SolidMolecular weight:409.0863Amiodarone Related Compound G
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C26H31I2NO4Molecular weight:675.03425Iscotrizinol Related Compound B (4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) (DISCONTINUED)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C36H43N7O5Color and Shape:White PowderMolecular weight:653.33257Moexipril Related Compound B ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2-b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C27H32N2O6Color and Shape:Off-White SolidMolecular weight:480.22604Eprosartan Related Compound D (4-(bromomethyl)benzoic acid) (DISCONTINUED)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormula:C8H7BrO2Color and Shape:White PowderMolecular weight:213.96294Gadoversetamide Related Compound A (DISCONTINUED)
Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, excluding cerium compounds, nesoiFormula:C17H27N4O10GdColor and Shape:White PowderMolecular weight:604.67Eprosartan Related Compound B (3-(thiophen-2-yl)propanoic acid) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C7H8O2SColor and Shape:White Beige SolidMolecular weight:156.0245Bemotrizinol Impurity Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Light Yellow PowderEprosartan Related Compound A ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H18N2O2S·HClColor and Shape:Off-White PowderMolecular weight:290.1089Cidofovir Related Compound A (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C10H18N3O6PColor and Shape:White Off-White PowderMolecular weight:307.09332Iscotrizinol Related Compound D (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C40H52N8O4Color and Shape:White PowderMolecular weight:708.41115Dihydrodaunorubicin Hydrochloride ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) (DISCONTINUED)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C27H31NO10·HClColor and Shape:PowderMolecular weight:565.17147Sibutramine Related Compound C (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or includedFormula:C17H26ClN·HClColor and Shape:White Crystalline PowderMolecular weight:316.3Iscotrizinol Related Compound F (Bis(2-ethylhexyl) 4,4'-({6-[(4-carbamoylphenyl)amino]-1,3,5-triazine-2,4-diyl}bis(azanediyl))dibenzoate) (DISCONTINUED)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C40H51N7O5Color and Shape:White Off-White PowderMolecular weight:709.39517Deacetylnorgestimate ((E)- and (Z)-17-deacetyl norgestimate mixture) (DISCONTINUED)
CAS:Estrogens and progestinsFormula:C21H29NO2Color and Shape:White PowderMolecular weight:327.21983Cinacalcet Related Compound B
Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C32H31F6NColor and Shape:Brown LiquidMolecular weight:543.6Pamabrom Related Compound A (8-Chlorotheophylline) (DISCONTINUED)
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C7H7ClN4O2Color and Shape:PowderMolecular weight:214.02575Modafinil Related Compound B (2-[(diphenylmethyl)sulfonyl]acetamide) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C15H15NO3SColor and Shape:White PowderMolecular weight:289.07726Thioridazine Related Compound F (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H24N2S2HClColor and Shape:Pale Green Light Blue PowderMolecular weight:356.13809Amiodarone Related Compound F
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H17IO3Molecular weight:420.02224Drometrizole Trisiloxane Related Compound A (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C17H17N3OColor and Shape:Yellow PowderMolecular weight:279.13716Amitraz Related Compound A (N-(2,4-Dimethylphenyl)formamide) (DISCONTINUED)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C9H11NOColor and Shape:PowderMolecular weight:149.08406Pravastatin Related Compound B (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygFormula:C23H36O7Color and Shape:PowderMolecular weight:424.2461Lufenuron Related Compound G (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate)
CAS:Ureines and their derivatives; salts thereofFormula:C21H12Cl2F2N2O5Color and Shape:PowderMolecular weight:480.00913Ethylhexyl Triazone Related Compound C (Bis(2-ethylhexyl) 4,4'-[(6-{[4-(ethoxycarbonyl)phenyl]amino}-1,3,5-triazine-2,4-diyl)bis(azanediyl)]dibenzoate) (DISCONTINUED)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C42H54N6O6Color and Shape:PowderMolecular weight:738.91Paroxetine Related Compound E Mixture (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix) (DISCONTINUED)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiColor and Shape:White Off-White Crystalline PowderModafinil Related Compound E (Bis(diphenylmethyl)disulfide) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C26H22S2Color and Shape:White PowderMolecular weight:398.11629Dicloxacillin Related Compound D (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H7Cl2NO3Color and Shape:PowderMolecular weight:270.9803Fludeoxyglucose Related Compound A (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H36N2O6Color and Shape:Colorless Light Yellow Crystalline SolidMolecular weight:376.25734Isocyclosporin A
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White PowderMolecular weight:1201.84137Ioxilan Related Compound A (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) (DISCONTINUED)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H9I3N2O4Color and Shape:White PowderMolecular weight:601.76965Drometrizole Trisiloxane Related Compound B (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C17H17N3OColor and Shape:Pale Yellow PowderMolecular weight:279.13716Probucol Related Compound C (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pestiFormula:C31H48O2S2Color and Shape:PowderMolecular weight:516.86Nisoldipine Related Compound E (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H22N2O5Color and Shape:Green SolidMolecular weight:370.15287Iscotrizinol Related Compound I (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C55H71N7O7Color and Shape:White PowderMolecular weight:941.5415Dalfampridine Related Compound A (4-Aminopyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C5H6N2OColor and Shape:White SolidMolecular weight:110.04801Sulfamethazine Related Compound A (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) (DISCONTINUED)
CAS:Sulfonamides, nesoiFormula:C7H10N4O2S·H2OColor and Shape:White PowderMolecular weight:232.06301Amiodarone Related Compound C
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H30INO3Molecular weight:519.12704Nefazodone Related Compound A (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) (PLANNED TO BE DISCONTINUED)
CAS:Compounds containing a pyrimidine ring (whether or notFormula:C13H18Cl2N2·HClColor and Shape:White PowderMolecular weight:272.0847Drometrizole Trisiloxane Related Compound E (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C31H59N3O5Si6Color and Shape:Pale Yellow LiquidMolecular weight:722.33Fentanyl Related Compound B (4-Anilinopiperidine)
CAS:Controlled ProductCompounds containing an unfused pyridine ring in the structure, nesoiFormula:C11H16N2Color and Shape:White PowderMolecular weight:176.13135Melphalan Enantiomer
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C13H18Cl2N2O2·HClMolecular weight:340.05121Loracarbef L-Isomer (DISCONTINUED)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H16ClN3O4·3H2OColor and Shape:PowderMolecular weight:403.82Open Ring N-Methyl Clopidogrel Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-(methyl(2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H18ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:359.05136Cyclosporin H
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White SolidMolecular weight:1201.84137Amitraz Related Compound B (N'-(2,4-Dimethylphenyl)-N-methylformimidamide) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:Aromatic imines and their derivatives, salts thereofFormula:C10H14N2Color and Shape:PowderMolecular weight:162.11572-Ethylhexan-1-ol (DISCONTINUED)
CAS:2-ethylhexan-1-ol (octyl alcohol)Formula:C8H18OColor and Shape:LiquidMolecular weight:130.22 g/molLevalbuterol Related Compound B (α-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) (DISCONTINUED)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C13H21N02Color and Shape:White PowderMolecular weight:205.17047Proguanil Related Compound C (1,5-bis(4-chlorophenyl)biguanide hydrochloride)
CAS:Aromatic imines and their derivatives, salts thereofFormula:C14H13Cl2N5·HClColor and Shape:White Crystalline PowderMolecular weight:321.0548Modafinil Related Compound D (Bis(diphenylmethyl)ether) (DISCONTINUED)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C26H22OColor and Shape:White PowderMolecular weight:350.16707Probucol Related Compound B (4,4'-dithio-bis(2,6-di-tert-butylphenol)) (DISCONTINUED)
Other aromatic organo-sulfur compounds (excluding pestiFormula:C28H42O2S2Color and Shape:Pale Yellow Crystalline SolidMolecular weight:474.77Cinacalcet Related Compound E
Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C10H11F3OColor and Shape:Colorless Clear Light Yellow Light Brown LiquidMolecular weight:204.0762Drometrizole Trisiloxane Related Compound C (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C24H37N3O3Si3Color and Shape:Colorless LiquidMolecular weight:499.83Orlistat Related Compound D (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) (DISCONTINUED)
CAS:Lactones, nesoiFormula:C29H53NO5Color and Shape:LiquidMolecular weight:495.39237Ethopabate Related Compound A (Methyl-4-acetamido-2-hydroxybenzoate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H11NO4Color and Shape:Tan PowderMolecular weight:209.06881Iscotrizinol Related Compound C (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C29H37ClN6O3Color and Shape:White Off-White PowderMolecular weight:552.26157Trospium Chloride Related Compound B ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H23NO3Color and Shape:White Off-White SolidMolecular weight:337.16779Iscotrizinol Related Compound G (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C51H64N8O6Color and Shape:PowderMolecular weight:884.49488Oxaliplatin Related Compound B ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II))
CAS:Inorganic or organic compounds of precious metals, whetFormula:C6H14N4O6PtColor and Shape:White Pale Yellow Crystalline PowderMolecular weight:433.28Amiodarone Related Compound B
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C23H25I2NO3Molecular weight:616.99239Chlorothiophene carboxylic acid (5-chlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H3ClO2SColor and Shape:Off-White Pale Yellow SolidMolecular weight:161.95423Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)
CAS:Other aromatic organo-sulfur compounds (excluding pestiFormula:C15H15NOSColor and Shape:White PowderMolecular weight:257.08744Zalcitabine Related Compound A (2',3'-Didehydro-2',3'-dideoxycytidine) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C9H11N3O3Color and Shape:PowderMolecular weight:209.23Ethylhexyl Triazone Related Compound A (2-ethylhexyl 4-aminobenzoate) (DISCONTINUED)
CAS:Aromatic amino-acids and their esters, other than thoseFormula:C15H23NO2Color and Shape:PlatesMolecular weight:249.35Clavam-2-carboxylate Potassium
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C6H6KNO4Color and Shape:White FilmMolecular weight:194.99339Iloperidone Related Compound A ([4'-(3-Chloropropoxy)-3'-methoxy]acetophenone) (DISCONTINUED)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives: chlordecone (iso)Formula:C12H15ClO3Color and Shape:PowderMolecular weight:242.07097Moexipril Related Compound C ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C35H46N2O11Color and Shape:White PowderMolecular weight:670.31016Epoprostenol Related Compound B (Sodium 5-(diphenylphosphinoyl)pentanoate) (DISCONTINUED)
Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormula:C17H18NaO3PColor and Shape:White PowderMolecular weight:324.08913Nisoldipine Related Compound D (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H22N2O6Color and Shape:Pale Yellow SolidMolecular weight:386.14779Eprosartan Related Compound C (2-(thiophen-2-ylmethyl)malonic acid) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C8H8O4SColor and Shape:White PowderMolecular weight:200.01433Nisoldipine Related Compound C (Isobutyl (Z)-2-(2-nitrobenzylidene)-3-oxobutanoate) (DISCONTINUED)
Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C15H17NO5Color and Shape:Pale Yellow SolidMolecular weight:291.11067Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid)
CAS:Compounds (excluding drugs and pesticides) containing aFormula:C25H30N2O7Color and Shape:PowderMolecular weight:470.20532-Chloro-1,3,2-dioxaphospholane-2-oxide
CAS:Formula:C2H4ClO3PPurity:95%Color and Shape:LiquidMolecular weight:142.47812,6-Bis(1-methylethyl)phenol
CAS:Formula:C12H18OPurity:98%Color and Shape:LiquidMolecular weight:178.2707Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-
CAS:Formula:C6H10N2O4PtPurity:98%Color and Shape:SolidMolecular weight:369.232611β,17α,21-Trihydroxypregn-4-ene-3,20-dione
CAS:Formula:C21H30O5Purity:98%Color and Shape:SolidMolecular weight:362.4599Ref: IN-DA003AAY
Discontinued product(2R,3R)-3,3',4',5,7-Pentahydroxyflavanone
CAS:Formula:C15H12O7Purity:98%Color and Shape:SolidMolecular weight:304.251617-Hydroxy-7-α-mercapto-3-oxo-17-α-pregn-4-ene-21-carboxylic acid-γ-lactone-7-acetate
CAS:Formula:C24H32O4SPurity:97%Color and Shape:SolidMolecular weight:416.5735b-D-Glucopyranoside,(3b,12b)-20-(b-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl2-O-b-D-glucopyranosyl-
CAS:Formula:C48H82O18Purity:98%Color and Shape:SolidMolecular weight:947.1539Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-
CAS:Formula:C24H23ClO2Purity:98%Color and Shape:SolidMolecular weight:378.89123,6-Dichloro-1,2,4,5-tetrazine
CAS:Formula:C2Cl2N4Purity:97%Color and Shape:SolidMolecular weight:150.95422,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-
CAS:Formula:C13H16N2O2Purity:98%Color and Shape:SolidMolecular weight:232.27831-(3-Dimethylaminopropyl)-3-ethylcarbodiimide
CAS:Formula:C8H17N3Purity:98%Color and Shape:LiquidMolecular weight:155.2407Ref: IN-DA003UUA
Discontinued productErgosta-5,7,22-trien-3-ol, (3b,22E)-
CAS:Formula:C28H44OPurity:95%Color and Shape:SolidMolecular weight:396.64842-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
CAS:Formula:C27H22Cl2N4Purity:98%Color and Shape:SolidMolecular weight:473.39645-(Ethylthio)-1H-tetrazole
CAS:Formula:C3H6N4SPurity:98%Color and Shape:SolidMolecular weight:130.17155-Amino-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
CAS:Formula:C9H14N4O5Purity:95%Color and Shape:SolidMolecular weight:258.2313Ref: IN-DA00E8UZ
Discontinued product18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-
CAS:Formula:C21H24O2Purity:99%Color and Shape:SolidMolecular weight:308.41412-Azido-1,3-diMethyliMidazoliniuM Hexafluorophosphate
CAS:Formula:C5H12F6N5PPurity:98%Color and Shape:SolidMolecular weight:287.1465
![Thioridazine Related Compound F (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1663063.webp&w=3840&q=75)
![Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445368.webp&w=3840&q=75)
![Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrah…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445608.webp&w=3840&q=75)
![Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I84B.webp&w=3840&q=75)
![Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA000Y8C.webp&w=3840&q=75)
![2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I3TE.webp&w=3840&q=75)
